Metro-Minnesota Community Oncology Research Consortium (MMCORC)

明尼苏达都会区社区肿瘤学研究联盟 (MMCORC)

• 批准号: 10227706
• 负责人: Daniel M Anderson
• 金额: $ 386.45万
• 依托单位: HEALTHPARTNERS INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10227706
• 关键词: Address; Advocate; American Cancer Society; American College of Radiology Imaging Network; Award; Awareness; Cancer Center; Cancer Control; Cancer Hospital; Cancer Patient; Cancer Research Project; Catchment Area; Clinic; Clinical; Clinical Research; Clinical Trials; Clinical Trials Support Unit; Clinics and Hospitals; Collaborations; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Community Physician; Comprehensive Cancer Center of Wake Forest University; Discipline of obstetrics; Eastern Cooperative Oncology Group; Enrollment; Ensure; Environment; Evaluation; Funding; Funding Opportunities; Future; Goals; Grant; Growth; Gynecologic Oncology; Gynecology; Health; Health Care Reform; Health Planning Councils; Health Professional; Hematology; Hospital Administrators; Hospitals; Image; Improve Access; Individual; Intervention; Knowledge; Malignant Neoplasms; Medical Oncology; Methods; Minnesota; Minority Groups; Modeling; National Cancer Institute; Nurse Practitioners; Oncologist; Oncology; Outcome; Palliative Care; Pamphlets; Participant; Patient advocacy; Patient-Focused Outcomes; Patients; Personal Satisfaction; Physician Assistants; Population Heterogeneity; Positioning Attribute; Prevention; Primary Health Care; Procedures; Process; Protocols documentation; Quality of life; Radiation Oncology; Radiology Specialty; Recording of previous events; Research; Research Institute; Research Personnel; Research Proposals; Resources; Rural; Services; Site; Southwest Oncology Group; Surgical Oncology; Testing; Thoracic Surgical Procedures; Time; Underrepresented Populations; Underserved Population; Universities; Wisconsin; advocacy organizations; base; cancer care; cancer clinical trial; cancer health disparity; cancer prevention; cancer therapy; care delivery; collaborative trial; community setting; design; disparity reduction; health care availability; health plan; improved; member; neuro-oncology; organizational structure; outreach program; patient population; precision medicine; programs; screening; social media; socioeconomics; success; symptom management; web site

Project Summary The Metro-Minnesota Community Oncology Research Consortium (MMCORC), formerly known as the Metro- Minnesota Community Clinical Oncology Program (MMCCOP), has a long history of success, as demonstrated by the ongoing commitment of is original members and the consortium's growth from 1979 to 2018. Today, MMCORC is an established community program that began through its National Cancer Institute (NCI)-funded Community Hospital Cancer Program Award. This program improved cancer care delivery in the community and was the cornerstone for the Community Clinical Oncology Program (CCOP) initiative. It received the initial NCI CCOP grant in 1983 and has been awarded subsequent CCOP grants in 3- to 5-year increments until the 5-year NCI Community Oncology Research Program (NCORP) grant in 2014. In 2010, hospitals, clinics, and oncologists in the MN Community Group Outreach Program joined MMCCOP, resulting in a metro-wide community cancer research program in Minneapolis-St. Paul. In 2014, MMCCOP received funding under the new NCORP grant program. In 2016, MMCCOP was renamed MMCORC to represent the disbanding of the NCI CCOP grant program and show the broad scope of oncology research services available to the community, consistent with a consortium model. MMCORC represents 25 hospital and clinics with a common approach and established mechanisms for identifying, enrolling, and following participants on NCI- sponsored treatment, cancer prevention and control, symptom management, and care delivery research protocols. The state health market remains extremely competitive and is constantly changing due to mergers and healthcare reform initiatives. Despite this environment, MMCORC hospitals and staff continue to collaborate and support the added time and expense of offering clinical research trials to patients in the communities we serve. The consortium incorporates a substantial segment of the oncology community and has provided a basis for communication, partnership, and collaboration among practicing oncologists, their hospital administrators, and other health professionals for 35 years. Combined, the consortium members see, on average, more than 17,170 new analytic cancer patients per year. In the consortium, 165 MD investigators represent medical oncology, hematology, and radiation and surgical oncology, including thoracic surgery, gynecologic oncology, radiology, neuro-oncology, obstetrics and gynecology, palliative care, and primary care, with 57 mid-level clinicians (nurse practitioners and physician assistants) considered associate investigators. MMCORC intends to continue to offer the community the most recent advances in cancer prevention, treatment, symptom management, and care delivery through continued affiliations with NCORP research bases such as Alliance, ECOG-ACRIN, NRG Oncology, SWOG via CTSU, URCC, and CCCWFU. By implementing proactive strategies to improve access and encourage participation from underrepresented and underserved groups, MMCORC is well positioned to achieve the goals of the NCORP set forth by the NCI.

项目摘要 大都会-明尼苏达州社区肿瘤学研究联盟(MMCORC)，前身为大都会-明尼苏达州- 明尼苏达州社区临床肿瘤学计划(MMCCOP)已经有很长的成功历史，正如所证明的那样 由于IS原始成员的持续承诺和该财团从1979年到2018年的增长。今天, MMCORC是一个成熟的社区项目，由国家癌症研究所(NCI)资助 社区医院癌症项目奖。这项计划改善了社区的癌症护理服务。 是社区临床肿瘤学计划(CCOP)倡议的基石。它收到了首个 1983年获得NCI CCOP奖助金，并在随后获得CCOP奖助金，每3至5年递增一次，直到 2014年为期5年的NCI社区肿瘤学研究计划(NCORP)赠款。2010年，医院、诊所和 MN社区小组外联计划中的肿瘤学家加入了MMCCOP，导致了全市范围的 明尼阿波利斯-圣彼得堡社区癌症研究计划保罗。2014年，MMCCOP获得了 新的NCORP赠款计划。2016年，MMCCOP更名为MMCORC，以代表解散 NCI CCOP赠款计划，并展示了可用于 社区，与联盟模式一致。MMCORC代表25家医院和诊所 确定、登记和跟踪NCI赞助的参与者的方法和建立的机制 治疗、癌症预防和控制、症状管理和护理提供研究方案。这个 州医疗市场仍然竞争激烈，并因合并和医疗保健而不断变化 改革举措。尽管有这样的环境，MMCORC医院和工作人员仍在继续合作和支持 为我们服务的社区的患者提供临床研究试验所需的额外时间和费用。 该联盟纳入了肿瘤学社区的相当一部分，并为 执业肿瘤学家、他们的医院管理人员和 其他健康专业人员已有35年的经验。加在一起，财团成员平均看到超过 每年新增17170名分析型癌症患者。在该联盟中，165名MD调查人员代表医疗 肿瘤学，血液学，放射和外科肿瘤学，包括胸外科，妇科肿瘤学， 放射科、神经肿瘤科、妇产科、姑息治疗和初级护理，有57个中级 临床医生(执业护士和医生助理)被认为是副研究员。 MMCORC打算继续为社区提供癌症预防方面的最新进展， 通过与NCORP研究的持续合作进行治疗、症状管理和护理提供 联盟、ECOG-ACRIN、NRG肿瘤学、通过CTSU的SWOG、URCC和CCCWFU等基地。通过 实施积极主动的战略，以改善机会并鼓励任职人数不足的人和 在服务不足的群体中，MMCORC处于有利地位，可以实现NCI设定的NCORP目标。